Thomsen RW, Nicolaisen SK, Hasvold P, et al. Elevated potassium levels in patients with congestive heart failure: occurrence, risk factors, and clinical outcomes: a Danish population-based cohort study. J Am Heart Assoc. 2018;7(11): e008912. https://doi.org/10.1161/JAHA.118.008912.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Collins AJ, Pitt B, Reaven N, et al. Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes. Am J Nephrol. 2017;46(3):213–21. https://doi.org/10.1159/000479802.

Article  CAS  PubMed  Google Scholar 

Núñez J, Bayés-Genís A, Zannad F, et al. Long-term potassium monitoring and dynamics in heart failure and risk of mortality. Circulation. 2018;137(13):1320–30. https://doi.org/10.1161/CIRCULATIONAHA.117.030576.

Article  CAS  PubMed  Google Scholar 

Ferreira JP, Rossignol P, Machu JL, et al. Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. Eur J Heart Fail. 2017;19:1284–93. https://doi.org/10.1002/ejhf.90.

Article  CAS  PubMed  Google Scholar 

Savarese G, Carrero JJ, Pitt B, et al. Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry. Eur J Heart Fail. 2018;20:1326–34. https://doi.org/10.1002/ejhf.1182.

Article  CAS  PubMed  Google Scholar 

Epstein M, Reaven NL, Funk SE, McGaughey KJ, Oestreicher N, Knispel J. Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors. Am J Managed Care. 2015;21:S212–20.

Google Scholar 

Rosano GMC, Tamargo J, Kjeldsen KP, et al. Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. European Hear J - Cardiovasc Pharmacother. 2018;4:180–8. https://doi.org/10.1093/ehjcvp/pvy015.

Article  Google Scholar 

McLean RM, Wang NX. Potassium. Adv Food Nutr Res. 2021;96:89–121. https://doi.org/10.1016/bs.afnr.2021.02.013.

Article  CAS  PubMed  Google Scholar 

Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective. Nat Rev Nephrol. 2011;7:75–84. https://doi.org/10.1038/nrneph.2010.175.

Article  CAS  PubMed  Google Scholar 

Palmer BF, Carrero JJ, Clegg DJ, et al. Clinical management of hyperkalemia. Mayo Clin Proc. 2021;96:744–62. https://doi.org/10.1016/j.mayocp.2020.06.014.

Article  CAS  PubMed  Google Scholar 

Ewart HS, Klip A. Hormonal regulation of the Na(+)-K(+)-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol. 1995;269(2 Pt 1):C295-311. https://doi.org/10.1152/ajpcell.1995.269.2.C295.

Article  CAS  PubMed  Google Scholar 

Allon M, Shanklin N. Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease. Kidney Int. 1991;40:1103–9. https://doi.org/10.1038/ki.1991.321.

Article  CAS  PubMed  Google Scholar 

Mihailidou AS, Buhagiar KA, Rasmussen HH. Na+ influx and Na(+)-K+ pump activation during short-term exposure of cardiac myocytes to aldosterone. Am J Physiol. 1998;274:C175–81. https://doi.org/10.1152/ajpcell.1998.274.1.C175.

Article  CAS  PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2022;24:4–131. https://doi.org/10.1093/eurheartj/ehab368.

Article  CAS  PubMed  Google Scholar 

Ranjitkar P, Greene DN, Baird GS, Hoofnagle AN, Mathias PC. Establishing evidence-based thresholds and laboratory practices to reduce inappropriate treatment of pseudohyperkalemia. Clin Biochem. 2017;50:663–9. https://doi.org/10.1016/j.clinbiochem.2017.03.007.

Article  PubMed  Google Scholar 

Roccaforte V, Daves M, Alfreijat A, et al. Spurious elevation of serum potassium concentration measured in samples with thrombocytosis. Diagnosis (Berl). 2016;3:71–4. https://doi.org/10.1515/dx-2016-0008.

Article  PubMed  Google Scholar 

Liu S, Zhang L, Weng H, Yang F, Jin H, Fan F, Zheng X, Yang H, Li H, Zhang Y, Li J. Association between average plasma potassium levels and 30-day mortality during hospitalization in patients with COVID-19 in Wuhan. China Int J Med Sci. 2021Jan 1;18(3):736–43. https://doi.org/10.7150/ijms.50965.

Article  CAS  PubMed  Google Scholar 

Pannall P, Rossi A. Potassium levels in serum and plasma. Clin Chim Acta. 1970;30(1):218–20. https://doi.org/10.1016/0009-8981(70)90211-1.

Article  CAS  PubMed  Google Scholar 

Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Martensson A, Hyltoft Petersen P, Simonsson P, Steensland H, Uldall A. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest. 2004;64:271–84.

Article  CAS  PubMed  Google Scholar 

Cooper LB, Savarese G, Carrero JJ, et al. Clinical and research implications of serum versus plasma potassium measurements. Eur J Heart Fail. 2019;21(4):536–7. https://doi.org/10.1002/ejhf.1371.

Article  PubMed  Google Scholar 

Seamark D, Backhouse S, Barber P, Hichens J, Salzmann M, Powell R. Transport and temperature effects on measurement of serum and plasma potassium. J R Soc Med. 1999;92(7):339–41. https://doi.org/10.1177/014107689909200703).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nijsten MW, de Smet BJ, Dofferhoff AS. Pseudohyperkalemia and platelet counts. N Engl J Med. 1991;325(15):1107. https://doi.org/10.1056/NEJM199110103251515).

Article  CAS  PubMed  Google Scholar 

Forsman RW. Why is the laboratory an afterthought for managed care organizations? Clin Chem. 1996;42:813–6.

Article  CAS  PubMed  Google Scholar 

Tromp J, van der Meer P. Hyperkalaemia: aetiology, epidemiology, and clinical significance. Eur Heart J Suppl. 2019;21(Suppl A):A6–11. https://doi.org/10.1093/eurheartj/suy028.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Humphrey T, Davids MR, Chothia MY, Pecoits-Filho R, Pollock C, James G. How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies. Clin Kidney J. 2022;15(4):727–37. https://doi.org/10.1093/ckj/sfab243.

Article  PubMed  Google Scholar 

Martín-Pérez M, Ruigómez A, Michel A, García Rodríguez AL. Impact of hyperkalaemia definition on incidence assessment implications for epidemiological research based on a large cohort study in newly diagnosed heart failure patients in primary care. Bmc Fam Pract. 2016;17:51. https://doi.org/10.1186/s12875-016-0448-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jain N, Kotla S, Little BB, Weideman RA, Brilakis ES, Reilly RF, Banerjee S. Predictors of hyperkalemia and death in patients with cardiac and renal disease. Am J Cardiol. 2012;15(109):1510–3. https://doi.org/10.1016/j.amjcard.2012.01.367.

Article  CAS  Google Scholar 

Rossignol P, Lainscak M, Crespo-Leiro MG, et al. Unravelling the interplay between hyperkalaemia, renin-angiotensin aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORPHeart Failure Long-Term Registry. Eur J Heart Fail. 2020;22:1378–89. https://doi.org/10.1002/ejhf.1793.

Article  CAS  PubMed  Google Scholar 

Fleet JL, Shariff SZ, Gandhi S, Weir MA, Jain AK, Garg AX. Validity of the International Classification of Diseases 10th revision code for hyperkalaemia in elderly patients at presentation to an emergency department and at hospital admission. BMJ Open. 2012;2(6):e002011. https://doi.org/10.1136/bmjopen-2012-002011.

Article  PubMed  PubMed Central  Google Scholar 

Conway R, Creagh D, Byrne DG, O’Riordan D, Silke B. Serum potassium levels as an outcome determinant in acute medical admissions. Clin Med (Lond). 2015;15:239–43. https://doi.org/10.7861/clinmedicine.15-3-239.

Article  PubMed  Google Scholar 

Nilsson E, Gasparini A, Ärnlöv J, et al. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system. Int J Cardiol. 2017;245:277–84. https://doi.org/10.1016/j.ijcard.2017.07.035.

Article  PubMed  Google Scholar 

Chang AR, Sang Y, Leddy J, et al. Antihypertensive medications and the prevalence of hyperkalemia in a large health system. Hypertension. 2016Jun;67(6):1181–8. https://doi.org/10.1161/HYPERTENSIONAHA.116.07363.

Article  CAS  PubMed  Google Scholar 

McMurray JJV, Ostergren J, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet. 2003;362:767–71. https://doi.org/10.1016/S0140-6736(03)14283-3.

Article  CAS  PubMed  Google Scholar 

Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359:2456–67.